×
模态框（Modal）标题
在这里添加一些文本
Close
Close
Submit
Cancel
Confirm
×
模态框（Modal）标题
×
Please choose a citation manager
RIS (ProCite, Reference Manager)
BibTeX
Content to export
Citation
Citation and abstract
Export
Close ×
Home
Journals Online
Just Accepted
Current Issue
Archive
Most Read
Most Download
Most Cited
E-mail Alert
中文
Home
About Journal
Instruction
Journals Online
Just Accepted
Current Issue
Archive
Most Read
Most Download
Most Cited
E-mail Alert
Editorial Board
Publishing Policy
Download
Contacts Us
中文
Author Login
Peer Review
Office Work
Editor-in-Chief
Volume 39 Issue 7
Directed：
National Medical Products Administration
Sponsored:
National Institutes for Food and Drug Control
Editor in Chief:
Sang Guowei
Edited & Published:
Editors Agency of
Chinese Pharmaceutical Affairs
ISSN:
1002-7777
CN:
11-2858/R
Highlights
More
Collections
More +
Current Issue
Archive
Most Download
Most Read
Most Cited
Volume 39 Issue 7
20 July 2025
Supervision & Administration
Overview of Additions and Revisions of the Standards for Compound and Single Herb Preparation of Traditional Chinese Medicine in Chinese Pharmacopoeia 2025 Edition (Volume I)
Li Hao, Ni Long, Hao Bo, Zhao Yuxin, Shen Mingrui, Zhang Qingbo, He Yi
2025, 39(7): 725-731.
https://doi.org/10.16153/j.1002-7777.2025-05-0055
Abstract
(
)
Download PDF
(
)
Supervision & Administration
Discussion on the Implementation of Drug Production Inspection under the Background of Informatization and Intelligence
Wang Xin, Cao Yi, Zhou Yong, Bai Jianxue, Xiao Jie
2025, 39(7): 732-738.
https://doi.org/10.16153/j.1002-7777.2025-02-0022
Abstract
(
)
Download PDF
(
)
Supervision & Administration
Impact of Bidding Access for Drugs with Generics Available on Drug Accessibility
Wu Siyu, Zhang Wen, Wang Linning, Chang Feng
2025, 39(7): 739-748.
https://doi.org/10.16153/j.1002-7777.2025-03-0033
Abstract
(
)
Download PDF
(
)
Quality Management
Enhancing Drug Standard Management to Foster High-Quality Development of the Pharmaceutical Industry
He Yingmei, Xie Nan, Ma Xiao, Guo Zhaohui, Guo Lirong, Yang Lingxia, Liu Zhihao, Zhang Jianmin, Yang Pengwei, Zhang Zihao
2025, 39(7): 749-755.
https://doi.org/10.16153/j.1002-7777.2025-05-0004
Abstract
(
)
Download PDF
(
)
Quality Management
Research on the Quality Risk Management of CDMO Enterprises CAR-T Cell Therapy Products in Co-Production
Wang Mei, Wu Zhi’ang
2025, 39(7): 756-763.
https://doi.org/10.16153/j.1002-7777.2025-03-0006
Abstract
(
)
Download PDF
(
)
Quality Management
Quality Analysis and Suggestions on Sampling Work of Bao’erning Pharmaceutical Preparations
Chen Jiao, Zhang Lei
2025, 39(7): 764-770.
https://doi.org/10.16153/j.1002-7777.2024-11-0038
Abstract
(
)
Download PDF
(
)
Quality Management
Study on Proficiency Testing of Determination of Zearalenone Residue in Coix Seed
Liu Lina, Chang Yan, Xiang Xinhua, Jin Hongyu, Wei Feng
2025, 39(7): 771-778.
https://doi.org/10.16153/j.1002-7777.2025-02-0018
Abstract
(
)
Download PDF
(
)
Regulatory Technology
Trend Analysis of Key Quality Control Items of Anti-Programmed Death Receptor 1 Monoclonal Antibody
Yang Yalan, Qi Zhiyun, Liu Chunyu, Cui Yongfei, Guo Luyun, Yu Chuanfei
2025, 39(7): 779-787.
https://doi.org/10.16153/j.1002-7777.2025-04-0027
Abstract
(
)
Download PDF
(
)
Regulatory Technology
Comparative Study and Reflectionon on Determining Methods for Water Activity of Drugs
Feng Jiangjiang, Qiu Ting, Lu Fang, Wu Yue, Shen Yulan
2025, 39(7): 788-794.
https://doi.org/10.16153/j.1002-7777.2025-04-0002
Abstract
(
)
Download PDF
(
)
More +
More +
More +
More +
More +
Links
More
